Synthesis of Flubromazepam Positional Isomers for Forensic Analysis.

Designer benzodiazepines have recently appeared in many forensic cases as legal alternatives to federally scheduled drugs such as diazepam (Valium) and alprazolam (Xanax). Though current forensic instrumental techniques are often sufficient for identifying novel psychoactive substances, they may not readily differentiate between potential positional isomers. Additionally, characterization data for positional isomers of known designer benzodiazepines are widely nonexistent. In this study, flubromazepam, a recognized designer benzodiazepine since 2012, was targeted for synthesis and characterization due to its potential for federal scheduling and current legal status within the United States. A practical synthetic method was developed to prepare purified reference materials for each positional isomer of flubromazepam in which the positions of the bromine and fluorine substituents were varied. Possible isomers (9 of the 12) were successfully prepared and used for further analysis.

Development of an eHealth System to Capture and Analyze Patient Sensor and Self-Report Data: Mixed-Methods Assessment of Potential Applications to Improve Cancer Care Delivery.

BACKGROUND: Capturing and Analyzing Sensor and Self-Report Data for Clinicians and Researchers (COMPASS) is an electronic health (eHealth) platform designed to improve cancer care delivery through passive monitoring of patients' health status and delivering customizable reports to clinicians. Based on data from sensors and context-driven administration of patient-reported outcome (PRO) measures, key indices of patients' functional status can be collected between regular clinic visits, supporting clinicians in the delivery of patient care. OBJECTIVE: The first phase of this project aimed to systematically collect input from oncology providers and patients on potential clinical applications for COMPASS to refine the system. METHODS: Ten clinicians representing various oncology specialties and disciplines completed semi-structured interviews designed to solicit clinician input on how COMPASS can best support clinical care delivery. Three cancer patients tested a prototype of COMPASS for 7 days and provided feedback. Interview data were tabulated using thematic content analysis to identify the most clinically relevant objective and PRO domains. RESULTS: Thematic content analysis revealed that clinicians were most interested in monitoring vital statistics, symptoms, and functional status, including the physical activity level (n=9), weight (n=5), fatigue (n=9), sleep quality (n=8), and anxiety (n=7). Patients (2 in active treatment and 1 in remission) reported that they would use such a device, were enthusiastic about their clinicians monitoring their health status, especially the tracking of symptoms, and felt knowing their clinicians were monitoring and reviewing their health status provided valuable reassurance. Patients would, however, like to provide some context to their data. CONCLUSIONS: Clinicians and patients both articulated potential benefits of the COMPASS system in improving cancer care. From a clinician standpoint, data need to be easily interpretable and actionable. The fact that patients and clinicians both see potential value in eHealth systems suggests wider adoption and utilization could prove to be a useful tool for improving care delivery.

Estimating activity and sedentary behavior from an accelerometer on the hip or wrist.

PURPOSE: Previously, the National Health and Examination Survey measured physical activity with an accelerometer worn on the hip for 7 d but recently changed the location of the monitor to the wrist. This study compared estimates of physical activity intensity and type with an accelerometer on the hip versus the wrist. METHODS: Healthy adults (n = 37) wore triaxial accelerometers (Wockets) on the hip and dominant wrist along with a portable metabolic unit to measure energy expenditure during 20 activities. Motion summary counts were created, and receiver operating characteristic (ROC) curves were then used to determine sedentary and activity intensity thresholds. Ambulatory activities were separated from other activities using the coefficient of variation of the counts. Mixed-model predictions were used to estimate activity intensity. RESULTS: The ROC for determining sedentary behavior had greater sensitivity and specificity (71% and 96%) at the hip than at the wrist (53% and 76%), as did the ROC for moderate- to vigorous-intensity physical activity on the hip (70% and 83%) versus the wrist (30% and 69%). The ROC for the coefficient of variation associated with ambulation had a larger AUC at the hip compared to the wrist (0.83 and 0.74). The prediction model for activity energy expenditure resulted in an average difference of 0.55 ± 0.55 METs on the hip and 0.82 ± 0.93 METs on the wrist. CONCLUSIONS: Methods frequently used for estimating activity energy expenditure and identifying activity intensity thresholds from an accelerometer on the hip generally do better than similar data from an accelerometer on the wrist. Accurately identifying sedentary behavior from a lack of wrist motion presents significant challenges.